References
- Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217–5236. doi:https://doi.org/10.1002/cam4.1501.
- Barra F, Maggiore ULR, Bogani G, et al. New prophylactics human papilloma virus (HPV) vaccines against cervical cancer. J Obstet Gynaecol. 2019;39(1):1–10. doi:https://doi.org/10.1080/01443615.2018.1493441.
- Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–104. doi:https://doi.org/10.1016/j.ijgo.2009.02.012.
- Naga CP, Gurram L, Chopra S, et al. The management of locally advanced cervical cancer. Curr Opin Oncol. 2018;30(5):323–329.
- Guth U, Hadwin RJ, Schotzau A, et al. Clinical outcomes and patterns of severe late toxicity in the era of chemo-radiation for cervical cancer. Arch Gynecol Obstet. 2012;285(6):1703–1711. doi:https://doi.org/10.1007/s00404-011-2193-2.
- Pfaendler KS, Wenzel L, Mechanic MB, et al. Cervical cancer survivorship: long-term quality of life and social support. Clin Ther. 2015;37(1):39–48. doi:https://doi.org/10.1016/j.clinthera.2014.11.013.
- Buda A, Fossati R, Colombo N, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. JCO. 2005;23(18):4137–4145. doi:https://doi.org/10.1200/JCO.2005.04.172.
- Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20(4):660–665. doi:https://doi.org/10.1093/annonc/mdn690.
- Vizza E, Corrado G, Mancini E, et al. Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: a case control study. Eur J Surg Oncol. 2015;41(1):142–147. doi:https://doi.org/10.1016/j.ejso.2013.08.018.
- Minig L, Colombo N, Zanagnolo V, et al. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB. Int J Gynecol Cancer. 2013;23(9):1647–1654. doi:https://doi.org/10.1097/IGC.0b013e3182a616d2.
- Yin M, Zhao F, Lou G, et al. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer. 2011;21(1):92–99.
- Gupta S, Maheshwari A, Parab P, et al. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol. 2018;36(16):1548–1555. doi:https://doi.org/10.1200/JCO.2017.75.9985.
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cervical Cancer. Version 42019.
- Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9(3):297–303. doi:https://doi.org/10.1016/S1470-2045(08)70074-3.
- NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/expand/D.
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cervical Cancer. Version 4.2019. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.
- Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137–1143. doi:https://doi.org/10.1056/NEJM199904153401501.
- Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154–1161. doi:https://doi.org/10.1056/NEJM199904153401503.
- Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–1613. doi:https://doi.org/10.1200/JCO.2000.18.8.1606.
- Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17(5):1339–1348. doi:https://doi.org/10.1200/JCO.1999.17.5.1339.
- Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144–1153. doi:https://doi.org/10.1056/NEJM199904153401502.
- Chemoradiotherapy for Cervical Cancer Meta-analysis C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. The Cochrane Database Syst Rev. 2010;(1):CD008285.
- Marchiole P, Cittadini G, Sala P, et al. Pre- and post-operative work-up in patients affected by early cervical cancer and eligible for fertility-sparing treatment: role of MRI with saline hydrocolpos. Abdom Imaging. 2010;35(3):271–279. doi:https://doi.org/10.1007/s00261-009-9511-1.
- Della Corte L, Barra F, Foreste V, et al. Advances in paclitaxel combinations for treating cervical cancer. Expert Opin Pharmacother. 2020;1–15.
- Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol. 2003;14(8):1278–1284.
- Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20(1):179–188. doi:https://doi.org/10.1200/JCO.2002.20.1.179.
- Kenter G, Greggi S, Vergote I, et al. Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994. JCO. 2019;37(15_suppl):5503–5503. doi:https://doi.org/10.1200/JCO.2019.37.15_suppl.5503.